跳至主要内容
临床试验/NCT07418437
NCT07418437Enrolling By Invitation不适用

Adapting and Pilot Testing a Loneliness Intervention for Cancer Survivors

University of Washington1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年3月9日最近更新:
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
36
试验地点
1
主要终点
Loneliness

研究概览

简要总结

Loneliness, which is the perceived lack of social support and connection, has increased substantially in the past decade and is adversely affecting the health and wellbeing of cancer survivors. The study seeks to test an intervention that builds on the principles of social prescribing, and targets loneliness to determine if it improves overall wellness and quality of life among cancer survivors.

详细描述

Our primary study question for our pilot is: "Is it feasible to test a social prescribing intervention adapted to the unique needs of cancer survivors?"

The team will conduct a pilot study that will adapt and test the feasibility of implementing a social prescribing intervention to connect participants with social opportunities and develop supportive social networks.

Specific aims:

  1. To adapt a social prescribing loneliness intervention for adult cancer survivors
  2. To assess the feasibility of implementing a social prescribing intervention to address loneliness in adult cancer survivors in a 2-arm RCT

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • English-speaking
  • A score greater or equal to 6 on the UCLA Loneliness 3-item Scale
  • Cancer survivor with a cancer diagnosis

排除标准

  • Are on palliative care or live in a controlled setting (i.e., assisted living, nursing home or inpatient treatment facility)
  • Have an upcoming scheduled surgery
  • Severe cognitive impairment or active psychosis

研究组 & 干预措施

Usual Care Group

Experimental

Participants will be randomized to the Usual Care group (N=18). Participants in this group will resume to their usual standard of care for 9 weeks.

干预措施: Usual Care (Behavioral)

Social Prescribing Group

Experimental

Participants will be randomized to the Social Prescribing group (N=18). Social Prescribing group participants will meet for 60 mins via Zoom, for 9-weeks.

干预措施: Social Prescribing Group (Behavioral)

结局指标

主要结局

Loneliness

时间窗: Baseline, 9 Weeks, 2 Month Follow Up

The primary outcome is to see changes in loneliness using the University of California, Los Angeles Loneliness Version 3 (UCLA). It contains 20 questions that ask about loneliness-related experiences. Loneliness score range 0-80 with 80 indicating a maximum value and severe loneliness.

次要结局

  • Social Connection(Baseline, 9 Weeks, 2 Month Follow Up)
  • Self-Efficacy(Baseline, 9 Weeks, 2 Month Follow Up)
  • Quality of Life Core 30(Baseline, 9 Weeks, 2 Month Follow Up)
  • PHQ-9(Baseline, 9 Weeks, 2 Month Follow Up)
  • GAD-7(Baseline, 9 Weeks, 2 Month Follow Up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sebastian Tong

Principal Investigator

University of Washington

研究点 (1)

Loading locations...

相似试验